Summary
ASTRAZENECA'S strategy of buying in medicines was dealt a major blow yesterday as one of its bright new hopes failed to pass a major milestone.
Tests revealed heart drug AGI-1067 created by American biotechnology firm ArtheroGenics was no better than the placebo in reducing plaque build-up in the arteries.See the full content of this document
Extract
Bitter Pill for Astra Over Heart Medicine
Shares fell 20p to 2861p, al...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Buyout Team Shows a Lot of Bottle | Glanville: Injuries Affecting Our Form | wayne suffers fan taunts [edition 3] | City Put On Measles Alert | Familiar Face to Head Houlton Library | Accounts Payable and Sarbanes-Oxley; Strengthening Your Internal Controls. | Recognition Day Today for Child Care Providers | 'the grudge 2' (director's cut)
